Please login to the form below
Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market
Published in eyeforpharma February 2016 by Rachel Howard
How large is the opportunity for pharma and healthcare companies in Taiwan?
In our latest article for eyeforpharma we explore Taiwan’s healthcare system, and look at the broader economic and demographic factors which need to be addressed when considering the opportunity for pharma and healthcare companies in Taiwan.
Find out more:
http://bit.ly/1UadDJA
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Rare diseases and orphan drugs: Our experience and expertise
Research Partnership
- Conducting research for publication video
Research Partnership
- Conference research case study
- How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Research Partnership
- Portfolio analysis: Using market research to master communications across a therapeutic category
Research Partnership
- EphMRA round up 2018
- EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Research Partnership
- Patients’willingness to pay
- Considerations when developing an appropriate pricing strategy in self-pay markets
Research Partnership
- About us
- Contact us
- How to advertise
- Site map
- All content copyright © PMGroup Worldwide Ltd 2018
